Revenue · 2016–2025

Amphastar Pharmaceuticals revenue

$720M−1.7% · FY2025

Amphastar Pharmaceuticals (AMPH) reported $720M in revenue for fiscal 2025, −1.7% year on year.

$255M2016$240M2017$295M2018$322M2019$350M2020$438M2021$499M2022$644M2023$732M2024$720M2025
Amphastar Pharmaceuticals — Revenue, 2016–2025
Fiscal yearRevenueChangeFiling
FY20252025-12-31$720M−1.7%Open →
FY20242024-12-31$732M+13.6%Open →
FY20232023-12-31$644M+29.1%Open →
FY20222022-12-31$499M+14.0%Open →
FY20212021-12-31$438M+25.1%Open →
FY20202020-12-31$350M+8.5%Open →
FY20192019-12-31$322M+9.4%Open →
FY20182018-12-31$295M+22.7%Open →
FY20172017-12-31$240M−5.9%Open →
FY20162016-12-31$255M—Open →

Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +12.2%

Revenue at companies of similar size

Full ranking by revenue →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Amphastar Pharmaceuticals revenue |url=https://companiesranked.com/en/company/amphastar-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Amphastar Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/amphastar-pharmaceuticals/revenue

BibTeX

@misc{companiesranked-en-company-amphastar-pharmaceuticals-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Amphastar Pharmaceuticals revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/amphastar-pharmaceuticals/revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001297184-26-000009 · February 26, 2026

{{cite web |title=Amphastar Pharmaceuticals revenue — 10-K (0001297184-26-000009) |url=https://www.sec.gov/Archives/edgar/data/1297184/000129718426000009/amph-20251231x10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Amphastar Pharmaceuticals overview